Navigation Links
Remergent(R) Announces the Launch of Four New Products Pioneers of DNA Repair Expand Anti-Aging Line

FREEPORT, N.Y., Feb. 4 /PRNewswire/ -- AGI Dermatics, the bio-pharmaceutical laboratory that pioneered DNA research for skincare will introduce four innovative products to the Remergent line: Advanced Retinol Therapy (1% retinol), Progressive Retinol Complex (0.4% retinol), Clarifying Concentrate2 and Complete Cleanser.

"The new products include our first retinol-based formulas and reinforce our commitment to harnessing the power of the industry's most effective anti-aging ingredients," said Daniel Yarosh, Ph.D., President of AGI Dermatics. "Although best known for our DNA repair enzyme technology, the Remergent brand is, at its heart, a superior anti-aging line with a full-range of products that complement each other to prevent, protect, treat and repair photo damage."

Remergent is the brand recommended by top dermatologists across the country to help repair the consequences of sun damage and reverse the signs of photo aged skin. Available from medical professionals, Remergent is the first product line to use sophisticated formulas to target DNA repair, barrier re-building, pigmentary issues, discolorations from the sun and other skin concerns. The introduction of the four new products boosts the scope and the efficacy of the current treatment products.

-- Advanced Retinol Therapy -- is an intensive skin perfecting treatment

formulated with 1% retinol, the highest non-prescription concentration

available, to firm the collagen network, accelerate cell turnover and

minimize the appearance of fine lines, wrinkles, age spots and uneven

skin tone without irritation.

-- Progressive Retinol Complex -- is a skin perfecting treatment

formulated with 0.4% retinol for use on more sensitive skin or as a

first line treatment to prepare skin for the more intensive benefits of

Advanced Retinol Therapy.

-- Clarifying Concentrate2 -- safely and gently diminishes the appearance

of localized discolorations on the face, hands, arms and shoulders.

-- Complete Cleanser -- provides pH-correction to condition and prepare

the skin for optimum formula delivery and treatment results.

The new Remergent retinol products will be introduced in early 2008. Currently, Remergent products are available from dermatologists and plastic surgeons. For more information, please visit or call 800-590-4244.

About AGI Dermatics

AGI Dermatics is the bio-pharmaceutical laboratory that has led the research of DNA repair of the skin for more than 20 years. Founded by Daniel B. Yarosh, PhD, AGI Dermatics specializes in skin photobiology, dedicating research and development to DNA repair, solar impact on the immune system, and cell-signaling in skin. The company's application of groundbreaking active ingredients and meticulously engineered liposome delivery systems is validated in controlled clinical studies and published in dozens of peer-reviewed scientific and medical journals.

SOURCE AGI Dermatics
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
2. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
3. Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer
4. Medarex Announces Completion of Sale of Shares in Genmab A/S
5. Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application
6. Rigel Announces Pricing of Public Offering of Common Stock
7. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Third Quarter Results on Friday, February 8, 2008
8. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
9. Immunosyn Announces Interview of CEO Stephen D. Ferrone by CEOCFO Interviews & News
10. CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2007 Financial Results
11. GeoPharma Announces Third Quarter Conference Call
Post Your Comments:
(Date:11/27/2015)... 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ... it has closed the sale of its global contrast ... NYSE Euronext) in a transaction valued at approximately $270 ... and a total of approximately 1,000 employees spread across ... St. Louis area. This entire workforce and ...
(Date:11/27/2015)... 27, 2015 ... of companion diagnostics is one of the ... with pharmaceutical companies and diagnostic manufacturers working ... . --> ... on global cancer biomarkers market spread across ...
(Date:11/26/2015)... , England , November 26, 2015 /PRNewswire/ ... Medical, an innovative medical device company specializing in imaging technologies, ... from the European Commission as part of the Horizon 2020 ... company to carry out a large-scale clinical trial in breast ...      (Logo: , --> ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE ... has adopted a stockholder rights plan (Rights Plan) in ... operating loss carryforwards (NOLs) under Section 382 of the ... --> PharmAthene,s use of its NOLs could ... change" as defined in Section 382 of the Code. ...
Breaking Biology Technology:
(Date:10/26/2015)... , October 26, 2015 /PRNewswire/ ... --> adds Biometrics ... to 2021 as well as Emerging ... research reports to its collection of ... . --> ...
(Date:10/23/2015)... 23, 2015 Research and Markets ( ... Voice Recognition Biometrics Market 2015-2019" report to their ... The global voice recognition biometrics market to grow ... --> --> The report, ... based on an in-depth market analysis with inputs from ...
(Date:10/22/2015)... Calif., Oct. 22, 2015  Synaptics (NASDAQ: SYNA ), a ... its first quarter ended September 30, 2015. ... of fiscal 2016 grew 66 percent over the comparable quarter last ... fiscal 2016 was $23.8 million, or $0.62 per diluted share. ... for the first quarter of fiscal 2016 grew 39 percent over ...
Breaking Biology News(10 mins):